Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data

This publication has 20 references indexed in Scilit:

• PENTA guidelines for the use of antiretroviral therapy, 2004
  HIV Medicine, 2004
• Use of Total Lymphocyte Count for Monitoring Response to Antiretroviral Therapy
  Clinical Infectious Diseases, 2004
• When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies
  AIDS, 2003
• Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings
  AIDS, 2003
• Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy
  AIDS, 2003
• Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians
  AIDS, 2003
• British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy
  HIV Medicine, 2001
• Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial
  Archives of Disease in Childhood, 2001
• T-lymphocyte subsets in West African children: Impact of age, sex, and season
  The Journal of Pediatrics, 1997
• CD4 and total lymphocyte counts as predictors of HIV disease progression
  QJM: An International Journal of Medicine, 1996